Report cover image

Pleural Diseases Market

Publisher Coherent Market Insights
Published Jul 18, 2023
Length 165 Pages
SKU # CMI18107644

Description

Pleural Diseases Market, By Disease Type (Pleurisy, Pleural Effusion, Pneumothorax, Mesothelioma, Others), By Diagnostic Tools (Imaging Techniques, Molecular Diagnostics, Thoracoscopy and Pleuroscopy), By Treatment Modalities (Medications, Thoracentesis and Pleurodesis, Minimally Invasive Interventions, Surgical Interventions), By End-User (Hospitals and Clinics, Diagnostic Centers, Research and Academic Institutions), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung’s structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging pleural diseases.

Market Dynamics:

Increasing prevalence of respiratory diseases, technological advancements in diagnostic tools and imaging and focus on personalized medicine is anticipated to drive growth of the global pleural diseases market over the forecast period. Moreover, increasing investments in research and development is also expected to boost the growth of the global pleural diseases market over the forecast period. Advancements in minimally invasive interventions, emerging biomarkers and precision medicine, integration of artificial intelligence (AI) and machine learning (ml), telemedicine and remote monitoring are expected to create growth opportunities for the global pleural diseases market during the forecast period.

However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the pleural diseases market over the forecast period.

Key features of the study:
  • This report provides in-depth analysis of the Pleural Diseases market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Pleural Diseases market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Johnson & Johnson, AstraZeneca, Novartis International AG, Roche Holding AG, Bristol Myers Squibb, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Bayer AG, Celgene Corporation,
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Pleural Diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Pleural Diseases market
Detailed Segmentation:
  • Global Pleural Diseases Market, By Disease Types:
  • Pleurisy
  • Pleural Effusion
  • Pneumothorax
  • Mesothelioma
  • Others
  • Global Pleural Diseases Market, By Diagnostic Tools:
  • Imaging Techniques
  • Molecular Diagnostics
  • Thoracoscopy and Pleuroscopy
  • Global Pleural Diseases Market, By Treatment Modalities:
  • Medications
  • Thoracentesis and Pleurodesis
  • Minimally Invasive Interventions
  • Surgical Interventions
  • Global Pleural Diseases Market, By End User:
  • Hospitals and Clinics
  • Diagnostic Centers
  • Research and Academic Institutions
  • Global Pleural Diseases Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & South Africa
  • Company Profile:
  • Johnson & Johnson
  • AstraZeneca
  • Novartis International AG
  • Roche Holding AG
  • Bristol Myers Squibb
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • Sanofi
  • AbbVie Inc.
  • Eli Lilly and Company
  • Takeda Pharmaceutical Company Limited
  • Bayer AG
  • Celgene Corporation

Table of Contents

165 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Diseases
Market Snapshot, By Diagnostic Tools
Market Snapshot, By Treatment Modalities
Market Snapshot, By End User
Market Snapshot, By Geography/Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing Prevalence of Respiratory diseases
Restraints
Limited Availability of Expertise and Resources
Opportunities
Emerging Biomarkers and Precision Medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Pleural Diseases Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Pleural Diseases Market , By Disease Types, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Pleurisy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Pleural Effusion
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Pneumothelioma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Mesothelioma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Pleural Diseases Market , By Diagnostic Tools, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Imaging Techniques
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Molecular Diagnostics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Thoracoscopy and Pleuroscopy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Global Pleural Diseases Market, By Treatment Modalities, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Medications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Thoracentesis and Pleurodesis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Minimally Invasive Interventions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Surgical Interventions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Global Pleural Diseases Market , By End User, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Diagnostic Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Research and Academic Institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Global Pleural Diseases Market , By Region, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools , 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools , 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools , 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools , 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
10. Competitive Landscape
Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AstraZeneca
Novartis International
Roche Holding AG
Bristol Myers Squibb
Merck & Co., Inc.
Pfizer Inc.
GlaxoSmithKline plc
Boehringer Ingelheim International GmbH
Sanofi
AbbVie Inc.
Eli Lily and Company
Takeda Pharmaceutical Company Limited
Bayer AG
Celgene Corporation
Analyst Views
11. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Pleural Diseases Market” - Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us